Claims
- 1. A pyridazinone of the general formula I ##STR13## wherein R is a bromine atom, or the cyano, group, and the tautomeric forms thereof.
- 2. A compound of the general formula I of claim 1 being 6-(3-cyano-4-morpholino-phenyl)-4,5-dihydro-3(2H)-pyridazinone, and the tautomeric forms thereof.
- 3. The compound of claim 1 wherein R is bromine.
- 4. A therapeutic composition for the treatment of thrombotic diseases comprising an effective amount of an antithrombotic active compound of formula I as claimed in claim 1 together with a pharmaceutically acceptable excipient.
- 5. A therapeutic composition as defined in claim 4, wherein in the antithrombotic active compound is 6-(3-cyano-4-morpholino-phenyl)-4,5-dihydro-3(2H)-pyridazinone or a tautomeric form thereof.
Priority Claims (1)
Number |
Date |
Country |
Kind |
1443/81 |
Mar 1981 |
CHX |
|
Parent Case Info
This is a continuation of application Ser. No. 758,833 filed on July 24, 1985, now U.S. Pat. No. 4,613,599, which in turn is a continuation of application Ser. No. 608,536 filed May 9, 1984 now abandoned, which is turn is a continuation of application Ser. No. 490,933 filed May 2, 1983 now abandoned, which in turn is a continuation-in-part of application Ser. No. 352,739 filed Feb. 26, 1982 now abandoned.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
3975388 |
Hakim et al. |
Aug 1976 |
|
Foreign Referenced Citations (1)
Number |
Date |
Country |
1488330 |
Oct 1977 |
GBX |
Non-Patent Literature Citations (1)
Entry |
Curran et al., Chemical Abstracts, vol. 77 (1972), No. 19664f. |
Continuations (3)
|
Number |
Date |
Country |
Parent |
758833 |
Jul 1985 |
|
Parent |
608536 |
May 1984 |
|
Parent |
490993 |
May 1983 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
352739 |
Feb 1982 |
|